These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 37380638)

  • 21. Baicalin alleviates bleomycin‑induced pulmonary fibrosis and fibroblast proliferation in rats via the PI3K/AKT signaling pathway.
    Zhao H; Li C; Li L; Liu J; Gao Y; Mu K; Chen D; Lu A; Ren Y; Li Z
    Mol Med Rep; 2020 Jun; 21(6):2321-2334. PubMed ID: 32323806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Icariside II modulates pulmonary fibrosis via PI3K/Akt/β-catenin pathway inhibition of M2 macrophage program.
    Deng L; Ouyang B; Tang W; Wang N; Yang F; Shi H; Zhang Z; Yu H; Chen M; Wei Y; Dong J
    Phytomedicine; 2024 Jul; 130():155687. PubMed ID: 38759312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thy-1 depletion and integrin β3 upregulation-mediated PI3K-Akt-mTOR pathway activation inhibits lung fibroblast autophagy in lipopolysaccharide-induced pulmonary fibrosis.
    Wan H; Xie T; Xu Q; Hu X; Xing S; Yang H; Gao Y; He Z
    Lab Invest; 2019 Nov; 99(11):1636-1649. PubMed ID: 31249375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sodium Propionate Attenuates the Lipopolysaccharide-Induced Epithelial-Mesenchymal Transition via the PI3K/Akt/mTOR Signaling Pathway.
    Chen D; Qiu YB; Gao ZQ; Wu YX; Wan BB; Liu G; Chen JL; Zhou Q; Yu RQ; Pang QF
    J Agric Food Chem; 2020 Jun; 68(24):6554-6563. PubMed ID: 32452677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycyrrhizic Acid Attenuates Pulmonary Fibrosis of Silicosis by Inhibiting the Interaction between HMGB1 and BRG1 through PI3K/Akt/mTOR Pathway.
    Niu Z; Lin J; Hao C; Xu X; Wang C; Dai K; Deng X; Deng M; Guo Y; Yao W
    Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
    Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
    Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antifibrotic action of Yifei Sanjie formula enhanced autophagy via PI3K-AKT-mTOR signaling pathway in mouse model of pulmonary fibrosis.
    Yu JZ; Ying Y; Liu Y; Sun CB; Dai C; Zhao S; Tian SZ; Peng J; Han NP; Yuan JL; Yan JY; Yang ZS
    Biomed Pharmacother; 2019 Oct; 118():109293. PubMed ID: 31401393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calycosin attenuates pulmonary fibrosis by the epithelial-mesenchymal transition repression upon inhibiting the AKT/GSK3β/β-catenin signaling pathway.
    Liu X; Shao Y; Zhang X; Ji X; Xie M; Liu H
    Acta Histochem; 2021 Jul; 123(5):151746. PubMed ID: 34217047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amifostine Analog, DRDE-30, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice.
    Arora A; Bhuria V; Hazari PP; Pathak U; Mathur S; Roy BG; Sandhir R; Soni R; Dwarakanath BS; Bhatt AN
    Front Pharmacol; 2018; 9():394. PubMed ID: 29740320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis.
    Qian W; Cai X; Qian Q; Zhang W; Wang D
    J Cell Mol Med; 2018 Sep; 22(9):4354-4365. PubMed ID: 29971947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nickle(II) ions exacerbate bleomycin-induced pulmonary inflammation and fibrosis by activating the ROS/Akt signaling pathway.
    Yang L; Lin Z; Wang Y; Li C; Xu W; Li Q; Yao W; Song Z; Liu G
    Environ Sci Pollut Res Int; 2018 Feb; 25(5):4406-4418. PubMed ID: 29185215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vertical inhibition of PI3K/Akt/mTOR signaling demonstrates in vitro and in vivo anti-fibrotic activity.
    Liang M; Lv J; Chu H; Wang J; Chen X; Zhu X; Xue Y; Guan M; Zou H
    J Dermatol Sci; 2014 Nov; 76(2):104-11. PubMed ID: 25258031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Berberine inhibits Smad and non-Smad signaling cascades and enhances autophagy against pulmonary fibrosis.
    Chitra P; Saiprasad G; Manikandan R; Sudhandiran G
    J Mol Med (Berl); 2015 Sep; 93(9):1015-31. PubMed ID: 25877860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydrogen inhalation attenuated bleomycin-induced pulmonary fibrosis by inhibiting transforming growth factor-β1 and relevant oxidative stress and epithelial-to-mesenchymal transition.
    Gao L; Jiang D; Geng J; Dong R; Dai H
    Exp Physiol; 2019 Dec; 104(12):1942-1951. PubMed ID: 31535412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspirin alleviates pulmonary fibrosis through PI3K/AKT/mTOR-mediated autophagy pathway.
    Peng J; Xiao X; Li S; Lyu X; Gong H; Tan S; Dong L; Sanders YY; Zhang X
    Exp Gerontol; 2023 Feb; 172():112085. PubMed ID: 36623738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effective-compounds of Jinshui Huanxian formula ameliorates fibroblast activation in pulmonary fibrosis by inhibiting the activation of mTOR signaling.
    Li J; Li K; Tian Y; Zhao P; Liu X; Li M; Bai Y
    Phytomedicine; 2023 Jan; 109():154604. PubMed ID: 36610143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of mTOR ameliorates bleomycin-induced pulmonary fibrosis by regulating epithelial-mesenchymal transition.
    Han Q; Lin L; Zhao B; Wang N; Liu X
    Biochem Biophys Res Commun; 2018 Jun; 500(4):839-845. PubMed ID: 29704504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Network pharmacology and experiments in vivo and in vitro reveal that the Jia-Wei-Bu-Shen-Yi-Qi formula (JWBSYQF) and its active ingredient baicalein ameliorate BLM-induced lung fibrosis in mice via PI3K/Akt signaling pathway.
    Shi H; Deng L; Zhou Y; Yu H; Huang X; Chen M; Lei Y; Dong J
    J Ethnopharmacol; 2023 Oct; 315():116691. PubMed ID: 37247682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. S-allyl-l-cysteine attenuates bleomycin-induced pulmonary fibrosis and inflammation via AKT/NF-κB signaling pathway in mice.
    Nie Y; Yu K; Li B; Hu Y; Zhang H; Xin R; Xiong Y; Zhao P; Chai G
    J Pharmacol Sci; 2019 Apr; 139(4):377-384. PubMed ID: 30928090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
    Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
    PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.